PA
RPRX icon

Parallel Advisors’s Royalty Pharma RPRX Stock Holding History

Parallel Advisors’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$279K Buy
4,974
+153
+3% +$7.96K ﹤0.01% 1065
2026
Q1 		$231K Buy
4,821
+145
+3% +$6.35K ﹤0.01% 1092
2025
Q4 		$181K Buy
4,676
+153
+3% +$5.83K ﹤0.01% 1142
2025
Q3 		$160K Buy
4,523
+35
+0.8% +$1.27K ﹤0.01% 1169
2025
Q2 		$162K Buy
4,488
+65
+1% +$2.15K ﹤0.01% 1108
2025
Q1 		$138K Buy
4,423
+798
+22% +$25.3K ﹤0.01% 1133
2024
Q4 		$92.5K Buy
3,625
+1,144
+46% +$30.3K ﹤0.01% 1313
2024
Q3 		$70.2K Buy
2,481
+757
+44% +$21K ﹤0.01% 1434
2024
Q2 		$45.5K Sell
1,724
-1,331
-44% -$36.9K ﹤0.01% 1580
2024
Q1 		$92.8K Buy
3,055
+173
+6% +$5.1K ﹤0.01% 1204
2023
Q4 		$81K Buy
2,882
+1,111
+63% +$30.5K ﹤0.01% 1204
2023
Q3 		$48.1K Buy
1,771
+652
+58% +$19.4K ﹤0.01% 1414
2023
Q2 		$34.4K Buy
1,119
+215
+24% +$7.28K ﹤0.01% 1588
2023
Q1 		$32.6K Buy
904
+741
+455% +$27.5K ﹤0.01% 1597
2022
Q4 		$6.44K Sell
163
-214
-57% -$8.93K ﹤0.01% 2216
2022
Q3 		$15K Buy
377
+203
+117% +$8.67K ﹤0.01% 1818
2022
Q2 		$7K Sell
174
-120
-41% -$4.92K ﹤0.01% 2144
2022
Q1 		$11K Buy
294
+34
+13% +$1.33K ﹤0.01% 1982
2021
Q4 		$10K Buy
260
+225
+643% +$8.74K ﹤0.01% 2120
2021
Q3 		$1K Buy
+35
New +$1.36K ﹤0.01% 2943

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Parallel Advisors's RPRX Position: Q2 2026 in Review

Parallel Advisors increased its Royalty Pharma (RPRX) stake by 3.2% in Q2 2026, buying an estimated $7.96K and bringing the position to 4,974 shares worth $279K. The position accounts for ﹤0.01% of the portfolio, ranked #1065.

Parallel Advisors first reported a position in RPRX in Q3 2021 and has held it in 20 quarters since. 645 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Parallel Advisors held 4,974 shares of Royalty Pharma worth $279K as of Q2 2026.
  • Parallel Advisors bought 153 Royalty Pharma shares in Q2 2026, an estimated $7.96K.
  • Royalty Pharma made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #1065 holding.
  • Parallel Advisors first reported a position in Royalty Pharma in Q3 2021 and has held it in 20 quarters since.
  • 645 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.